181 related articles for article (PubMed ID: 19563342)
1. Primed CD8(+) T-cell responses to allogeneic endothelial cells are controlled by local complement activation.
Raedler H; Yang M; Lalli PN; Medof ME; Heeger PS
Am J Transplant; 2009 Aug; 9(8):1784-95. PubMed ID: 19563342
[TBL] [Abstract][Full Text] [Related]
2. Locally produced C5a binds to T cell-expressed C5aR to enhance effector T-cell expansion by limiting antigen-induced apoptosis.
Lalli PN; Strainic MG; Yang M; Lin F; Medof ME; Heeger PS
Blood; 2008 Sep; 112(5):1759-66. PubMed ID: 18567839
[TBL] [Abstract][Full Text] [Related]
3. Decay accelerating factor can control T cell differentiation into IFN-gamma-producing effector cells via regulating local C5a-induced IL-12 production.
Lalli PN; Strainic MG; Lin F; Medof ME; Heeger PS
J Immunol; 2007 Nov; 179(9):5793-802. PubMed ID: 17947652
[TBL] [Abstract][Full Text] [Related]
4. Donor deficiency of decay-accelerating factor accelerates murine T cell-mediated cardiac allograft rejection.
Pavlov V; Raedler H; Yuan S; Leisman S; Kwan WH; Lalli PN; Medof ME; Heeger PS
J Immunol; 2008 Oct; 181(7):4580-9. PubMed ID: 18802060
[TBL] [Abstract][Full Text] [Related]
5. Complement regulates CD4 T-cell help to CD8 T cells required for murine allograft rejection.
Vieyra M; Leisman S; Raedler H; Kwan WH; Yang M; Strainic MG; Medof ME; Heeger PS
Am J Pathol; 2011 Aug; 179(2):766-74. PubMed ID: 21704012
[TBL] [Abstract][Full Text] [Related]
6. Complement-dependent enhancement of CD8+ T cell immunity to lymphocytic choriomeningitis virus infection in decay-accelerating factor-deficient mice.
Fang C; Miwa T; Shen H; Song WC
J Immunol; 2007 Sep; 179(5):3178-86. PubMed ID: 17709533
[TBL] [Abstract][Full Text] [Related]
7. IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.
Liu J; Lin F; Strainic MG; An F; Miller RH; Altuntas CZ; Heeger PS; Tuohy VK; Medof ME
J Immunol; 2008 May; 180(9):5882-9. PubMed ID: 18424707
[TBL] [Abstract][Full Text] [Related]
8. Immune cell-derived C3a and C5a costimulate human T cell alloimmunity.
Cravedi P; Leventhal J; Lakhani P; Ward SC; Donovan MJ; Heeger PS
Am J Transplant; 2013 Oct; 13(10):2530-9. PubMed ID: 24033923
[TBL] [Abstract][Full Text] [Related]
9. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
10. Blocking properdin, the alternative pathway, and anaphylatoxin receptors ameliorates renal ischemia-reperfusion injury in decay-accelerating factor and CD59 double-knockout mice.
Miwa T; Sato S; Gullipalli D; Nangaku M; Song WC
J Immunol; 2013 Apr; 190(7):3552-9. PubMed ID: 23427256
[TBL] [Abstract][Full Text] [Related]
11. Complement modulation of T cell immune responses during homeostasis and disease.
Clarke EV; Tenner AJ
J Leukoc Biol; 2014 Nov; 96(5):745-56. PubMed ID: 25210145
[TBL] [Abstract][Full Text] [Related]
12. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice.
Pritchard MT; McMullen MR; Stavitsky AB; Cohen JI; Lin F; Edward Medof M; Nagy LE
Gastroenterology; 2007 Mar; 132(3):1117-1126. PubMed ID: 17383432
[TBL] [Abstract][Full Text] [Related]
13. Critical role of C5a in sickle cell disease.
Vercellotti GM; Dalmasso AP; Schaid TR; Nguyen J; Chen C; Ericson ME; Abdulla F; Killeen T; Lindorfer MA; Taylor RP; Belcher JD
Am J Hematol; 2019 Mar; 94(3):327-337. PubMed ID: 30569594
[TBL] [Abstract][Full Text] [Related]
14. Dynamic regulation of B cell complement signaling is integral to germinal center responses.
Cumpelik A; Heja D; Hu Y; Varano G; Ordikhani F; Roberto MP; He Z; Homann D; Lira SA; Dominguez-Sola D; Heeger PS
Nat Immunol; 2021 Jun; 22(6):757-768. PubMed ID: 34031614
[TBL] [Abstract][Full Text] [Related]
15. Genetic and pharmacologic inhibition of complement impairs endothelial cell function and ablates ovarian cancer neovascularization.
Nunez-Cruz S; Gimotty PA; Guerra MW; Connolly DC; Wu YQ; DeAngelis RA; Lambris JD; Coukos G; Scholler N
Neoplasia; 2012 Nov; 14(11):994-1004. PubMed ID: 23226093
[TBL] [Abstract][Full Text] [Related]
16. Complement C5a promotes antigen cross-presentation by Peyer's patch monocyte-derived dendritic cells and drives a protective CD8
Kim SH; Cho BH; Kim KS; Jang YS
Cell Rep; 2021 Apr; 35(2):108995. PubMed ID: 33852847
[TBL] [Abstract][Full Text] [Related]
17. Complement Regulation in Human Tenocytes under the Influence of Anaphylatoxin C5a.
Silawal S; Kohl B; Shi J; Schulze-Tanzil G
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803624
[TBL] [Abstract][Full Text] [Related]
18. Anaphylatoxin C5a contributes to the pathogenesis of cisplatin-induced nephrotoxicity.
Pan H; Shen Z; Mukhopadhyay P; Wang H; Pacher P; Qin X; Gao B
Am J Physiol Renal Physiol; 2009 Mar; 296(3):F496-504. PubMed ID: 19144695
[TBL] [Abstract][Full Text] [Related]
19. Complement c5a receptor facilitates cancer metastasis by altering T-cell responses in the metastatic niche.
Vadrevu SK; Chintala NK; Sharma SK; Sharma P; Cleveland C; Riediger L; Manne S; Fairlie DP; Gorczyca W; Almanza O; Karbowniczek M; Markiewski MM
Cancer Res; 2014 Jul; 74(13):3454-65. PubMed ID: 24786787
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stem cells alleviate acute kidney injury by down-regulating C5a/C5aR pathway activation.
Tang M; Zhang K; Li Y; He QH; Li GQ; Zheng QY; Zhang KQ
Int Urol Nephrol; 2018 Aug; 50(8):1545-1553. PubMed ID: 29594894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
